Jeff Sherman is Co-Founder and Chief Technology Officer at Zephyr AI, where he leads the architecture of secure, scalable AI and data platforms that help partners match therapies to patients and bring precision medicine to scale. He previously served as Interim CEO of Zephyr AI. Jeff is also a Founding Partner at Red Cell Partners, an incubation firm building rapidly scalable technology in healthcare and defense, and Co-Founder of Adaje Inc., a SaaS company applying machine learning to bond, swap, and credit modeling.

Before Zephyr and Red Cell, Jeff was a Machine Learning Architect at Rally Health (acquired by UnitedHealth Group), where he led the design and deployment of a large-scale recommendation engine leveraging healthcare and behavioral data. Earlier, at BBN Technologies, he worked on DARPA/IARPA programs spanning natural language processing, computer vision, sensor fusion, and graph mining.

Jeff holds an MS in Computer Science from the University of Pennsylvania and a BS in Computer Science from George Mason University. He co-founded Zephyr AI with the conviction that advanced machine learning, paired with large-scale real-world data, can accelerate and de-risk drug development—making medicine more effective and accessible for patients.